Cannassure Therapeutics Ltd (CSURE)
Market Open
16 Jul, 15:25
TASE TASE Primary TASE 43. 20
ILA +0.7
+1.6471%
- Market Cap
- P/E Ratio
- Div Yield
25,777 Volume
- Eps
42.5 ILA
Previous Close Want to track CSURE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
CSURE trading today higher at 43.2 ILA, an increase of 1.6471% from yesterday's close, completing a monthly increase of 0% or 43.2 ILA. Over the past 12 months, CSURE stock gained 0%.
CSURE is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on TASE (ILA).
CSURE Chart
Cannassure Therapeutics Ltd (CSURE) FAQ
What is the stock price today?
The current price is 43.20 ILA.
On which exchange is it traded?
Cannassure Therapeutics Ltd is listed on TASE.
What is its stock symbol?
The ticker symbol is CSURE.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, no market cap data is available.
Has Cannassure Therapeutics Ltd ever had a stock split?
No, there has never been a stock split.
Cannassure Therapeutics Ltd Profile
| - Industry | - Sector | H.E Evyatar Cohen CEO | TASE Exchange | IL0001110134 ISIN |
| Israel Country | 2 Employees | - Last Dividend | 17 Mar 2024 Last Split | - IPO Date |
Overview
Cannassure Therapeutics Ltd is an Israel-based company dedicated to the cultivation and production of medical cannabis. Founded in 2016 and headquartered in Ashdod, Israel, it has positioned itself within the medical cannabis industry, focusing on the development of high-quality cannabis products for patients. Their operations embody the cultivation of cannabis plants under controlled conditions, ensuring that the products meet strict medical standards and cater to the needs of individuals seeking relief through medicinal cannabis.
Products and Services
- Medical Cannabis Oils - These oils are extracted from high-grade medical cannabis, designed for patients searching for an alternative form of medication. The precise extraction processes guarantee the preservation of beneficial cannabinoids and terpenes, providing a potent and effective remedy for various conditions.
- Indoor Inflorescences - Cultivated within the controlled environment of indoor facilities, these premium cannabis flowers are specifically grown to maintain consistent quality and cannabinoid profiles. Suitable for patients who require reliable strength and purity in their medicinal cannabis.
- Select Inflorescences - A curated selection of cannabis flowers, characterized by their exceptional quality and unique properties. These are tailored for connoisseurs and individuals with specific therapeutic needs, showcasing the best of what Cannassure has to offer.
- Value Inflorescences - These cannabis flowers offer an effective solution for patients seeking medicinal benefits at a more accessible price point. While they are more budget-friendly, they still adhere to Cannassure’s commitment to quality and efficacy.
- Cannavix - This product line may represent Cannassure’s proprietary or specialized formulations, indicating a focus on innovation within the therapeutic cannabis market. Although details are not specified, Cannavix likely encompasses products or technologies developed to enhance the patient experience with medical cannabis.
Contact Information
Address: 2 Hahadarim Street
Phone: 972 7 65313245
Website: https://cannassure.life
